Why do health technology assessment coverage recommendations for the same drugs differ across settings? Applying a mixed methods framework to systematically compare orphan drug decisions in four European countries
Crossref DOI link: https://doi.org/10.1007/s10198-016-0823-0
Published Online: 2016-08-18
Published Print: 2017-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nicod, Elena http://orcid.org/0000-0001-6798-9923
Funding for this research was provided by:
European Commission (305983)
License valid from 2016-08-18